Why the study?
Does low molecular weight heparin improve safety and efficacy compared to unfractionated heparin as bridging therapy in patients after mechanical prosthetic heart valve surgery?
Does low molecular weight heparin improve safety and efficacy compared to unfractionated heparin as bridging therapy in patients after mechanical prosthetic heart valve surgery?
Authors
No takes yet. Share an insight, caveat, or question.
Highlights the ongoing controversy and lack of clear guidelines regarding the optimal bridging anticoagulation strategy after mechanical prosthetic heart valve surgery.
Meurin et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: